Search results query ec: 2.7.12.1

Found 235 chains in Genus chains table. Displaying 101 - 150. Applied filters: Proteins

Total Genus	Sequence Length	pdb	Title
119	386	5lxdA	Crystal structure of dyrk2 in complex with eht 1610 (compound 2)
114	384	5lxcA	Crystal structure of dyrk2 in complex with eht 5372 (compound 1)
67	281	5ljjA	Crystal structure of human mps1 (ttk) in complex with reversine
80	280	4cvaA	Mps1 kinase with 3-aminopyridin-2-one inhibitors
116	336	6ft9A	Crystal structure of clk1 in complex with inhibitor 16
74	279	6h3kA	Introduction of a methyl group curbs metabolism of pyrido[3,4-d]pyrimidine mps1 inhibitors and enables the discovery of the phase 1 clinical candidate bos172722.
112	337	6g33A	Crystal structure of clk1 in complex with 5-iodotubercidin
121	355	6fyrA	X-ray structure of clk3-kd(gp-[275-632], non-phos.)/cpd-2 at 1.42a
117	340	6fylA	X-ray structure of clk2-kd(136-496)/cx-4945 at 1.95a
109	337	6g33B	Crystal structure of clk1 in complex with 5-iodotubercidin
118	349	6fykA	X-ray structure of clk2-kd(136-496)/indazole1 at 2.39a
110	336	6fyiA	X-ray structure of clk2-kd(130-496)/tg003 at 2.6a
110	348	6fypA	X-ray structure of clk3-kd(gp-[275-632], non-phos.)/cx-4945 at 2.29a
112	334	6fyoA	X-ray structure of clk1-kd(148-484)/cpd-2 at 2.32a
111	332	6fyvA	X-ray structure of clk4-kd(146-480)/cx-4945 at 2.46a
117	356	6ft7A	Crystal structure of clk3 in complex with compound 8a
121	338	6ft8A	Crystal structure of clk1 in complex with inhibitor 8g
107	347	6eipA	Dyrk1a in complex with xmd8-62e
110	347	6eijA	Dyrk1a in complex with hg-8-60-1
108	347	6eiqA	Dyrk1a in complex with xmd14-124
113	347	6eifA	Dyrk1a in complex with xmd7-117
112	347	6eilA	Dyrk1a in complex with xmd8-49
104	347	6eivA	Dyrk1a in complex with jwd-065
102	347	6ej4A	Dyrk1a in complex with xmd7-112
118	347	6eisA	Dyrk1a in complex with jwc-055
29	127	6c4uA	Engineered fha with myc-ptbd peptide
77	279	6b4wA	Ttk in complex with inhibitor
120	404	5ztnA	The crystal structure of human dyrk2 in complex with curcumin
115	350	6a1fA	Crystal structure of human dyrk1a in complex with compound 14
120	347	6a1gA	Crystal structure of human dyrk1a in complex with compound 32
126	395	5y86A	Crystal structure of kinase
85	451	5xzwA	Crystal structure of rad53 1-466
86	450	5xzvA	Crystal structure of rad53 1-466 in complex with amp-pnp
109	347	5a4tA	Dyrk1a in complex with nitrile benzothiazole fragment
112	347	5a54A	Dyrk1a in complex with nitro benzothiazole fragment
120	347	5a4qA	Dyrk1a in complex with chloro benzothiazole fragment
109	347	5a4eA	Dyrk1a in complex with methoxy benzothiazole fragment
111	347	5a4lA	Dyrk1a in complex with fluoro benzothiazole fragment
116	349	4yu2A	Crystal structure of dyrk1a with harmine-derivatized annh-75 inhibitor
73	281	4d2sA	Human ttk in complex with a dyrk1b inhibitor
72	279	4cv8A	Mps1 kinase with 3-aminopyridin-2-one inhibitors
76	280	4cv9A	Mps1 kinase with 3-aminopyridin-2-one inhibitors
81	279	4c4eA	Structure-based design of orally bioavailable pyrrolopyridine inhibitors of the mitotic kinase mps1
77	280	4c4gA	Structure-based design of orally bioavailable pyrrolopyridine inhibitors of the mitotic kinase mps1
77	279	4c4hA	Structure-based design of orally bioavailable pyrrolopyridine inhibitors of the mitotic kinase mps1
78	279	4c4iA	Structure-based design of orally bioavailable pyrrolopyridine inhibitors of the mitotic kinase mps1
88	280	4c4fA	Structure-based design of orally bioavailable pyrrolopyridine inhibitors of the mitotic kinase mps1
74	279	4c4jA	Structure-based design of orally bioavailable pyrrolopyridine inhibitors of the mitotic kinase mps1
82	279	4bi1A	Scaffold focused virtual screening: prospective application to the discovery of ttk inhibitor
127	409	4azfA	Human dyrk2 in complex with leucettine l41